Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation...
Read moreHalozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen Biotech, Inc. has initiated...
Read more
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint...
Read more
Servier, Pfizer In and Cellectis announced that preliminary results from two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR...
Read moreEisai Co., Ltd. announced that the latest data on its oral dual orexin receptor antagonist lemborexant and its oral beta...
Read moreThe Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN)...
Read moreRgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today preliminary data from...
Read moreNovartis has announced full results from the positive phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod)...
Read more
Servier and GeNeuro announced post hoc analyses of 6-month data from the CHANGE-MS Phase 2b study of GNbAC1 for the...
Read moreRoche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
